Latest Strategic Collaborations News

Lincoln Minerals has refreshed its leadership and shifted its corporate strategy towards copper discovery, advancing exploration plans at its Minbrie Project and forging key partnerships in graphite and iron ore development.

Impact Minerals reports significant advancements in its High Purity Alumina projects, a strategic collaboration with US battery innovator C4V, and renewed exploration activities in NSW’s Broken Hill region.

Imugene Limited has reported compelling clinical trial results for its off-the-shelf CAR T therapy, azer-cel, alongside FDA validation and a strategic collaboration, while managing cash flow amid cost reductions.

Locksley Resources has made significant strides at its Mojave Project, advancing drilling, securing major US institutional funding, and forging key partnerships to establish a domestic supply chain for critical antimony and rare earth elements.

Optiscan Imaging Ltd has made significant strides in clinical studies and regulatory readiness, partnering with Australian Clinical Labs and launching new cancer imaging trials as it prepares for multiple FDA submissions in 2026.

Noxopharm has successfully completed dosing in its HERACLES clinical trial for SOF-SKN™, demonstrating strong safety and tolerability. The company also secured a new overseas partnership and its first US patent for the Sofra platform.

Neurizon Therapeutics has cleared a major regulatory hurdle with the FDA lifting the clinical hold on its lead drug NUZ-001 and secured a comprehensive $33 million funding package to advance its pivotal ALS trial.

AdAlta Limited has launched its 'East to West' cellular immunotherapy operations through a strategic collaboration with Shanghai Cell Therapy Group to co-develop BZDS1901, an innovative CAR-T therapy targeting mesothelioma and other solid cancers. The company also strengthened its balance sheet by raising $2.8 million via private placements and repaying key investment agreements.

Sovereign Metals has successfully recovered a high-value heavy rare earth concentrate from its Kasiya project in Malawi, while securing a strategic collaboration with the World Bank’s IFC to underpin sustainable development and financing.

NuEnergy Gas Limited reported a cash outflow in Q4 2025 but secured a binding gas sales agreement and a strategic funding collaboration to advance its Indonesian coal bed methane projects.

Immutep Limited has entered a strategic collaboration with Dr. Reddy’s, receiving a A$30 million upfront payment and potential milestones up to A$528 million, while reporting promising clinical progress across multiple cancer immunotherapy trials.

Starpharma reports strong progress in strategic collaborations and internal drug development, alongside a 70% surge in Viraleze™ online sales and a solid $18.2 million cash position.